Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response?

Clin Cancer Res. 2006 Oct 1;12(19):5608-10. doi: 10.1158/1078-0432.CCR-06-1152.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / diagnostic imaging*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • ErbB Receptors / antagonists & inhibitors*
  • Fluorodeoxyglucose F18*
  • Gefitinib
  • Glucose / pharmacokinetics
  • Humans
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / drug therapy
  • Quinazolines / therapeutic use*
  • Radionuclide Imaging

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Fluorodeoxyglucose F18
  • ErbB Receptors
  • Glucose
  • Gefitinib